or
Remember me
Back
... think about it .. if the majority of these “vaccine candidates” have significant side effects - and have low efficacy given that they were all developed so fast ... R107 will be in the spotlight if it can boast very little side effects.. and if it can combat COVID better than these trial vaccines??
With millions.. and millions infected around the world... remember we’ve got a world wide patent for R107
Very pivotal... and exciting times ahead for Kaly!
A daily snapshot of everything from market open to close.